Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells

被引:155
作者
Hall, Matthew D. [1 ]
Salam, Noeris K. [2 ]
Hellawell, Jennifer L. [1 ]
Fales, Henry M. [3 ]
Kensler, Caroline B. [3 ]
Ludwig, Joseph A. [4 ]
Szakacs, Gergely [5 ]
Hibbs, David E. [2 ]
Gottesman, Michael M. [1 ]
机构
[1] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
[2] Univ Sydney, Fac Pharm, Pharmaceut Chem Div, Grp Biomol Struct & Informat, Sydney, NSW 2006, Australia
[3] NHLBI, Lab Appl Mass Spectrometry, NIH, Bethesda, MD 20892 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX 77030 USA
[5] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary
基金
美国国家卫生研究院; 澳大利亚研究理事会;
关键词
PRIMARY CYTOTOXICITY EVALUATION; RIBONUCLEOTIDE REDUCTASE; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; IRON CHELATORS; PHASE-I; CANCER; INHIBITOR; DISCOVERY; TRANSPORTERS; DERIVATIVES;
D O I
10.1021/jm800861c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have recently identified a new class of compounds that selectively kill cells that express P-glycoprotein (P-gp, MDR1), the ATPase efflux pump that confers multidrug resistance on cancer cells. Several isatin-beta-thiosemicarbazones from our initial study have been validated and a range of analogues synthesized and tested. A number demonstrated improved MDR1-selective activity over the lead, NSC73306 (1). Pharmacophores for cytotoxicity and MDR1 selectivity were generated to delineate the structural features required for activity. The MDR1-selective pharmacophore highlights the importance of aromatic/hydrophobic features at the N4 position of the thiosemicarbazone and the reliance on the isatin moiety as key bioisosteric contributors. Additionally, a quantitative structure-activity relationship (QSAR) model that yielded a cross-validated correlation coefficient of 0.85 effectively predicts the cytotoxicity of untested thiosemicarbazones. Together, the models serve as effective approaches for predicting structures with MDR1-selective activity and aid in directing the search for the mechanism of action of 1.
引用
收藏
页码:3191 / 3204
页数:14
相关论文
共 45 条
[1]  
Agrawal K C, 1978, Prog Med Chem, V15, P321, DOI 10.1016/S0079-6468(08)70259-5
[2]  
[Anonymous], MACROMODEL VERS 9 1
[3]  
ANTHOLINE W, 1977, MOL PHARMACOL, V13, P89
[4]   Sunitinib maleate [J].
Atkins, M ;
Jones, CA ;
Kirkpatrick, P .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :279-280
[5]   A HISTORY OF THE DISCOVERY AND CLINICAL-APPLICATION OF ANTIVIRAL DRUGS [J].
BAUER, DJ .
BRITISH MEDICAL BULLETIN, 1985, 41 (04) :309-314
[6]   Synthesis of novel 5-substituted indirubins as protein kinases inhibitors [J].
Beauchard, Anne ;
Ferandin, Yoan ;
Frere, Stephane ;
Lozach, Olivier ;
Blairvacq, Melina ;
Meijer, Laurent ;
Thiery, Valerie ;
Besson, Thierry .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (18) :6434-6443
[7]   The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes [J].
Beraldo, H ;
Gambino, D .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (01) :31-39
[8]  
BROCKMAN RW, 1956, CANCER RES, V16, P167
[10]   Pharmacophore-based discovery of ligands for drug transporters [J].
Chang, Cheng ;
Ekins, Sean ;
Bahadduri, Praveen ;
Swaan, Peter W. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (12-13) :1431-1450